Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    19300261 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting
Has Results
Bevacizumab Eliminates the Angiogenic Threat for Retinopathy of Prematurity
Condition: Retinopathy of Prematurity
Interventions: Drug: Bevacizumab;   Procedure: Conventional Laser for ROP

Study has passed its completion date and status has not been verified in more than two years.